Robert William Gebel v. HHS - Influenza, Guillain-Barré syndrome (2024)
Case summary [AI summaries can sometimes make mistakes]
Robert William Gebel filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that he suffered Guillain-Barré syndrome (GBS) as a result of an influenza vaccine administered on October 9, 2019. The respondent conceded that Mr.
Gebel is entitled to compensation, agreeing that his condition met the criteria set forth in the Vaccine Injury Table and its Qualifications and Aids to Interpretation. A ruling on entitlement was issued on August 7, 2023, finding Mr.
Gebel entitled to compensation. Subsequently, on December 7, 2023, the respondent filed a proffer on award of compensation, proposing an award of $117,589.22.
This amount was comprised of $117,000.00 for pain and suffering and $589.22 for out-of-pocket medical and related expenses. Mr.
Gebel agreed with the proffered award. The Chief Special Master issued a decision awarding Mr.
Gebel the lump sum of $117,589.22, representing compensation for all damages available under the Vaccine Act. The petition was filed on August 7, 2023, and the final decision awarding damages was issued on January 12, 2024.
Source PDFs
USCOURTS-cofc-1_22-vv-01484